HomeNewsNeuroscience

  • Rituximab shows efficacy in RRMS and Progressive MS patients, recent study underlines

    • May 31, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Parkinson’s drug ALK4290 by Alkahest receives Grant for Preclinical Evaluation

    • May 31, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • EMA Validates MAA Submission for Acorda’s INBRIJA for Parkinson’s

    • May 31, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Fingolimod, in MS patients, offers treatment satisfaction and improves Quality of life, study reinforces

    • May 27, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Non Motor symptoms for Parkinson’s more common in women as compared to men, study states

    • May 27, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Court confirms validity of UCB’s Vimpat patent for Epilepsy

    • May 25, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Zosano Announces new trial results for its Headache drug

    • May 25, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Ofatumumab shows efficacy in RRMS, highlight trial results

    • May 25, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New ADHD tool may improve disease diagnosis efficiency, study finds

    • May 25, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Teva Confirms September PDUFA Date for Fremanezumab

    • May 24, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more